Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1992 Jun;60(6):2329–2336. doi: 10.1128/iai.60.6.2329-2336.1992

Immune responses of systemic and mucosal lymphoid organs to Pnu-Imune vaccine as a function of age and the efficacy of monophosphoryl lipid A as an adjuvant.

M Garg 1, B Subbarao 1
PMCID: PMC257162  PMID: 1587600

Abstract

A murine model system was established to study immune responses to the Pnu-Imune vaccine, which is made up of 23 different pneumococcal capsular polysaccharides. In this animal model, antibody-forming cell responses to 21 of 23 individual polysaccharides in the vaccine were detected. The Pnu-Imune vaccine elicited good antibody responses from the spleens and mesenteric lymph nodes (MLN) of young mice, whereas a variety of other peripheral lymph nodes were unresponsive. The immunoglobulin M plaque-forming cell (PFC) response in the spleen to the Pnu-Imune vaccine (given intraperitoneally or subcutaneously) decreased dramatically with increasing age. However, the spleen and MLN differed in their susceptibility to an age-associated decline in immune function. While the PFC responses in the spleen declined with age, the PFC response in the mucosa-associated MLN did not decline with age but instead remained constant over the entire age span of 4 to 28 months studied. These studies showed that the spleen, peripheral lymph nodes, and MLN did not demonstrate parallel age-associated defects in antibody responses to pneumococcal polysaccharides when the antigen was administered systematically. Also, the deficient splenic antibody response to Pnu-Imune vaccine in aged mice could be enhanced by injecting a combination of Pnu-Imune vaccine and the nontoxic adjuvant monophosphoryl lipid A. Moreover, an immunoglobulin G response was induced when the immunogen was a mixture of vaccine and adjuvant.

Full text

PDF
2329

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allardyce R. A., Bienenstock J. The mucosal immune system in health and disease, with an emphasis on parasitic infection. Bull World Health Organ. 1984;62(1):7–25. [PMC free article] [PubMed] [Google Scholar]
  2. Amlot P. L., Grennan D., Humphrey J. H. Splenic dependence of the antibody response to thymus-independent (TI-2) antigens. Eur J Immunol. 1985 May;15(5):508–512. doi: 10.1002/eji.1830150516. [DOI] [PubMed] [Google Scholar]
  3. Baker P. J., Hiernaux J. R., Fauntleroy M. B., Stashak P. W., Prescott B., Cantrell J. L., Rudbach J. A. Ability of monophosphoryl lipid A to augment the antibody response of young mice. Infect Immun. 1988 Dec;56(12):3064–3066. doi: 10.1128/iai.56.12.3064-3066.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Baker P. J., Stashak P. W., Amsbaugh D. F., Prescott B. Characterization of the antibody response to type 3 pneumococcal polysaccharide at the cellular level. I. Dose-response studies and the effect of prior immunization on the magnitude of the antibody response. Immunology. 1971 Apr;20(4):469–480. [PMC free article] [PubMed] [Google Scholar]
  5. Baker P. J., Stashak P. W., Prescott B. Use of erythrocytes sensitized with purified pneumococcal polysaccharides for the assay of antibody and antibody-producing cells. Appl Microbiol. 1969 Mar;17(3):422–426. doi: 10.1128/am.17.3.422-426.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bienenstock J. The mucosal immunologic network. Ann Allergy. 1984 Dec;53(6 Pt 2):535–540. [PubMed] [Google Scholar]
  7. Bohnsack J. F., Brown E. J. The role of the spleen in resistance to infection. Annu Rev Med. 1986;37:49–59. doi: 10.1146/annurev.me.37.020186.000405. [DOI] [PubMed] [Google Scholar]
  8. Bolan G., Broome C. V., Facklam R. R., Plikaytis B. D., Fraser D. W., Schlech W. F., 3rd Pneumococcal vaccine efficacy in selected populations in the United States. Ann Intern Med. 1986 Jan;104(1):1–6. doi: 10.7326/0003-4819-104-1-1. [DOI] [PubMed] [Google Scholar]
  9. Callard R. E., Basten A., Waters L. K. Immune function in aged mice. II. B-cell function. Cell Immunol. 1977 Jun 1;31(1):26–36. doi: 10.1016/0008-8749(77)90003-x. [DOI] [PubMed] [Google Scholar]
  10. Carozzi S., Salit M., Cantaluppi A., Nasini M. G., Barocci S., Cantarella S., Lamperi S. Effect of monophosphoryl lipid A on the in vitro function of peritoneal leukocytes from uremic patients on continuous ambulatory peritoneal dialysis. J Clin Microbiol. 1989 Aug;27(8):1748–1753. doi: 10.1128/jcm.27.8.1748-1753.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Cebra J. J., Gearhart P. J., Kamat R., Robertson S. M., Tseng J. Origin and differentiation of lymphocytes involved in the secretory IgA responses. Cold Spring Harb Symp Quant Biol. 1977;41(Pt 1):201–215. doi: 10.1101/sqb.1977.041.01.026. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Dhar R., Ogra P. L. Local immune responses. Br Med Bull. 1985 Jan;41(1):28–33. doi: 10.1093/oxfordjournals.bmb.a072019. [DOI] [PubMed] [Google Scholar]
  13. Dijkstra J., Mellors J. W., Ryan J. L., Szoka F. C. Modulation of the biological activity of bacterial endotoxin by incorporation into liposomes. J Immunol. 1987 Apr 15;138(8):2663–2670. [PubMed] [Google Scholar]
  14. Gallatin W. M., Weissman I. L., Butcher E. C. A cell-surface molecule involved in organ-specific homing of lymphocytes. Nature. 1983 Jul 7;304(5921):30–34. doi: 10.1038/304030a0. [DOI] [PubMed] [Google Scholar]
  15. Goud S. N., Kaplan A. M., Subbarao B. Antibody responses to thymic independent antigens in the peripheral and mesenteric lymph nodes of mice. Reg Immunol. 1990 Jan-Feb;3(1):1–7. [PubMed] [Google Scholar]
  16. Goud S. N., Kaplan A. M., Subbarao B. Primary antibody responses to thymus-independent antigens in the lungs and hilar lymph nodes of mice. Infect Immun. 1990 Jul;58(7):2035–2041. doi: 10.1128/iai.58.7.2035-2041.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Goud S. N., Muthusamy N., Subbarao B. Differential responses of B cells from the spleen and lymph node to TNP-Ficoll. J Immunol. 1988 May 1;140(9):2925–2930. [PubMed] [Google Scholar]
  18. Gray B. M., Dillon H. C., Jr Clinical and epidemiologic studies of pneumococcal infection in children. Pediatr Infect Dis. 1986 Mar-Apr;5(2):201–207. doi: 10.1097/00006454-198603000-00009. [DOI] [PubMed] [Google Scholar]
  19. LaForce F. M., Eickhoff T. C. Pneumococcal vaccine: an emerging consensus. Ann Intern Med. 1988 May;108(5):757–759. doi: 10.7326/0003-4819-108-5-757. [DOI] [PubMed] [Google Scholar]
  20. Mosier D. E., Zaldivar N. M., Goldings E., Mond J., Scher I., Paul W. E. Formation of antibody in the newborn mouse: study of T-cell-independent antibody response. J Infect Dis. 1977 Aug;136 (Suppl):S14–S19. doi: 10.1093/infdis/136.supplement.s14. [DOI] [PubMed] [Google Scholar]
  21. Pasanen V. J., Asofsky R., Baker P. J. Synthesis of two classes of antibody, gammaM and gammaG or gammaM and gammaA, by identical cells. Amplification of the antibody response to pneumococcal polysaccharide type III. J Exp Med. 1979 May 1;149(5):1227–1237. doi: 10.1084/jem.149.5.1227. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Ribi E., Cantrell J. L., Takayama K., Qureshi N., Peterson J., Ribi H. O. Lipid A and immunotherapy. Rev Infect Dis. 1984 Jul-Aug;6(4):567–572. doi: 10.1093/clinids/6.4.567. [DOI] [PubMed] [Google Scholar]
  23. Roghmann K. J., Tabloski P. A., Bentley D. W., Schiffman G. Immune response of elderly adults to pneumococcus: variation by age, sex, and functional impairment. J Gerontol. 1987 May;42(3):265–270. doi: 10.1093/geronj/42.3.265. [DOI] [PubMed] [Google Scholar]
  24. SISKIND G. W., PATERSON P. Y., THOMAS L. INDUCTION OF UNRESPONSIVENESS AND IMMUNITY IN NEWBORN AND ADULT MICE WITH PNEUMOCOCCAL POLYSACCHARIDE. J Immunol. 1963 Jun;90:929–934. [PubMed] [Google Scholar]
  25. Sims R. V., Steinmann W. C., McConville J. H., King L. R., Zwick W. C., Schwartz J. S. The clinical effectiveness of pneumococcal vaccine in the elderly. Ann Intern Med. 1988 May;108(5):653–657. doi: 10.7326/0003-4819-108-5-653. [DOI] [PubMed] [Google Scholar]
  26. Smith A. M. The effects of age on the immune response to type III pneumococcal polysaccharide (SIII) and bacterial lipopolysaccharide (LPS) in BALB/c, SJL/J, and C3H mice. J Immunol. 1976 Feb;116(2):469–474. [PubMed] [Google Scholar]
  27. Subbarao B., Mosier D. E. Induction of B lymphocyte proliferation by monoclonal anti-Lyb 2 antibody. J Immunol. 1983 May;130(5):2033–2037. [PubMed] [Google Scholar]
  28. Szewczuk M. R., Campbell R. J., Jung L. K. Lack of age-associated immune dysfunction in mucosal-associated lymph nodes. J Immunol. 1981 Jun;126(6):2200–2204. [PubMed] [Google Scholar]
  29. Thoman M. L., Weigle W. O. The cellular and subcellular bases of immunosenescence. Adv Immunol. 1989;46:221–261. doi: 10.1016/s0065-2776(08)60655-0. [DOI] [PubMed] [Google Scholar]
  30. Tomai M. A., Solem L. E., Johnson A. G., Ribi E. The adjuvant properties of a nontoxic monophosphoryl lipid A in hyporesponsive and aging mice. J Biol Response Mod. 1987 Apr;6(2):99–107. [PubMed] [Google Scholar]
  31. Verghese A., Berk S. L. Bacterial pneumonia in the elderly. Medicine (Baltimore) 1983 Sep;62(5):271–285. doi: 10.1097/00005792-198309000-00002. [DOI] [PubMed] [Google Scholar]
  32. Vieira P., Rajewsky K. The half-lives of serum immunoglobulins in adult mice. Eur J Immunol. 1988 Feb;18(2):313–316. doi: 10.1002/eji.1830180221. [DOI] [PubMed] [Google Scholar]
  33. Vosika G. J., Barr C., Gilbertson D. Phase-I study of intravenous modified lipid A. Cancer Immunol Immunother. 1984;18(2):107–112. doi: 10.1007/BF00205743. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Yarkoni E., Wang L., Bekierkunst A. Stimulation of macrophages by cord factor and by heat-killed and living BCG. Infect Immun. 1977 Apr;16(1):1–8. doi: 10.1128/iai.16.1.1-8.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES